HiRO - Harvest Integrated Research Organization - ANZ (formerly PharmaSols)

What HiRO - Harvest Integrated Research Organization - ANZ (formerly PharmaSols) does

HiRO (Harvest Integrated Research Organization), formerly PharmaSols, is a privately held full-service global clinical research organization (CRO) headquartered in the United States, with offices in Somerset, New Jersey and Excelsior, Minnesota. The company delivers end-to-end clinical trial services to biotech and pharmaceutical sponsors of all sizes across more than 85 countries spanning APAC, ANZ, Europe, and North America, and reports a workforce of more than 500 professionals and a cumulative base of 1,600+ clinical trials delivered over 30+ years.

The service portfolio comprises eight core offerings — Clinical Data Science, Clinical Operations, Quality Assurance, Medical Monitoring, Regulatory Affairs, Pharmacovigilance, Medical Writing, and a Functional Service Provider (FSP) delivery model — orchestrated through the proprietary HiRO Linkage™ methodology that links People, Systems, Processes, Oversight, Data, and Collaboration. Therapeutic and modality coverage spans Oncology, Rare Diseases, CNS, Dermatology, Metabolic disorders, Healthy Volunteers, Radiopharmaceuticals, and Cell and Gene Therapy. The company's competitive narrative emphasizes discipline, agility, transparency, and inspection-ready governance.

Commercially, HiRO operates an enterprise field sales motion targeting biotech and pharma sponsors via RFP-driven engagement, with no publicly disclosed pricing. Revenue is generated through professional-services engagements (project-based, multi-year contracts) with biotech and pharmaceutical companies. The company holds no disclosed patents or trademarks, has not announced funding rounds, and discloses no management team. In July 2025, HiRO signed a Site Alliance Agreement with Monash Health at BIO Asia-Taiwan, signaling an ecosystem build-out in the ANZ region.

Name

HiRO - Harvest Integrated Research Organization - ANZ (formerly PharmaSols)

Legal name

HiRO

Website

https://en.harvestiro.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Clinical Research Organization Services

NAICS

Scientific Research and Development Services (5417)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Functional Service Providers (FSP) & Resourcing CROs (HLAGAAAM), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

Keywords

• Clinical research services
• Clinical trial management
• Contract research organization
• Biopharmaceutical services
• Regulatory affairs consulting

Headquarters

HQ city

Somerset

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. CRO Clinical Trial Services: Full-service clinical research organization providing end-to-end clinical trial services including clinical data science, clinical operations, regulatory affairs, medical writing, medical monitoring, pharmacovigilance, and quality assurance. Revenue is generated through professional services engagements with biotechs, pharmaceutical companies, and bio companies.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

HiRO is a full-service modern global Contract Research Organization (CRO) delivering end-to-end clinical trial services to biotechnology and pharmaceutical sponsors. The company provides eight core service modules — Clinical Data Science, Clinical Operations, Quality Assurance, Medical Monitoring, Regulatory Affairs, Pharmacovigilance, Medical Writing, and a Functional Service Provider (FSP) delivery model — orchestrated through its proprietary HiRO Linkage approach across APAC, ANZ, Europe, and North America.

Product overview

HiRO is a full-service modern global CRO delivering end-to-end clinical trial services through a unified platform of connected service modules. The portfolio comprises eight core service offerings: Clinical Data Science (biometrics-driven analysis), Clinical Operations (study execution and site coordination), Quality Assurance (inspection-ready governance), Medical Monitoring (clinical oversight and safety evaluation), Regulatory Affairs (global regulatory compliance), Pharmacovigilance (safety case management and reporting), Medical Writing (regulatory document preparation), and a Functional Service Provider (FSP) delivery model. These services are orchestrated through the proprietary HiRO Linkage™ approach, which links People, Systems, Processes, Oversight, Data, and Collaboration across 85+ countries to deliver 1,600+ clinical trials.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Data Science

Quantifiable outcome

• 1,600+ clinical trials delivered
• +2 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Monash HealthcoreStrategic or Co-development Partner · 1 July 2025HiRO and Monash Health signed a Site Alliance Agreement at BIO Asia-Taiwan to formalize a partnership aimed at speeding up complex clinical trials. The partnership provides HiRO with formalized site access and collaborative trial execution capabilities with Monash Health's research infrastructure.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Parexel: Large global full-service CRO now under EQT/Goldman Sachs ownership. Competes with HiRO for biotech and pharma clinical trial work, with overlapping full-service portfolio and broader geographic reach.
• ICON plc: Top-tier global CRO following Labcorp Drug Development acquisition. Competes with HiRO across full-service clinical trials, FSP, and therapeutic expertise, with much larger scale and broader geographic reach.
• Syneos Health: Large global CRO with full-service clinical development capabilities and a strong biotech segment. Overlaps with HiRO in therapeutic breadth and enterprise field sales motion, though at significantly larger scale.
• IQVIA: Largest global CRO with technology, data, and full-service clinical operations. Overlaps with HiRO in enterprise clinical trial services and therapeutic expertise, with unmatched scale and proprietary data assets.
• Charles River Laboratories: Global CRO with strong early-stage and safety/pharmacovigilance capabilities. Comparable to HiRO in clinical operations and pharmacovigilance service lines, with broader preclinical and manufacturing footprint.

Emerging players

• CTI Clinical Trial & Consulting Services: Mid-sized full-service CRO with therapeutic expertise in rare diseases, oncology, and cell/gene therapy. Closely comparable to HiRO in size, therapeutic specialization, and biotech customer focus.
• Tigermed: China-headquartered full-service CRO with growing international footprint. Comparable to HiRO in APAC-rooted clinical trial services and biotech/mid-pharma customer focus, though larger in scale.

Direct peers

• Worldwide Clinical Trials: Mid-tier global CRO focused on complex therapeutic areas and biotech/specialty pharma. Comparable to HiRO in scale, therapeutic specialization, and full-service clinical trial delivery.
• Medpace: Mid-to-large full-service CRO with a strong biotech and small/mid-pharma client focus. Directly comparable to HiRO in service model, biotech customer base, and emphasis on disciplined, high-quality execution.
• Novotech: Asia-Pacific focused full-service CRO with strong biotech and mid-cap pharma client base. Direct competitor to HiRO in APAC/ANZ clinical trial delivery, with overlapping therapeutic expertise and similar enterprise field sales motion.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/hiroanz

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HiRO - Harvest Integrated Research Organization - ANZ (formerly PharmaSols)